OPTICALLY ACTIVE BETA-AMINO ACID DERIVATIVES AND THEIR SALTS, AND PROCESSES FOR PRODUCING THE SAME

Abstract: Optically active B-amino acid derivatives and having the following formula: wherein COOR¹ is an esterified or unesterified carboxyl group; R² is hydrogen or a C 1-10 acyl or esterified carboxyl group and their salts, and novel compounds which permit important intermediate for the synthesis of 1B-methylcarbapenem derivatives to be produced in an efficient way.

Description: This invention relates to optically active β-amino acid derivatives and their salts, and in particular to novel, optically active (2R, 3R, 4S, 5R)-3-amino-2,5-dimethyl-5-pentanolide-4-carboxylic acid derivatives and their salts and processes for producing the same. Carbapenem antibiotics such as Thienamycin, PS-5, etc. are increasingly attracting a great deal of attention because of their potent antimicrobial activity. However, these compounds suffer from some serious defects, for example, that they are chemically unstable and, after in vivo administration, develop nephrotoxicity through breakdown in the kidney. Recently, it was reported that 1β-methylcarbapenem compounds derived from Thienamycin through incorporating a methyl group into the 1 position of its carbapenem skeleton can overcome the above-described defects and provide the excellent characteristic properties. With reference to the method of synthesis for such kind of compounds, there have been known, for example, the methods as described in "Heterocycles", vol. 21, pp. 29 (1984) and "Tetrahedon Letters", vol. 26 pp. 583 and 587 (1985). Nevertheless, the above-described methods encounter great difficulties in synthesizing a given desirable stereoisomer in a stereoselective manner. The present inventors, after intensive, repeated research work, found that the optically active compounds of the general formula I being provided with every chiralities of 1β-methylcarbapenem compounds can be synthesized with ease, and the finding has resulted in the completion of this invention. These compounds permit important intermediates for the synthesis of 1β-methylcarbapenem derivatives to be produced in an extremely efficient way. For instance, the compound (11), which is prepared as described in Example 15, is an important intermediate from which is obtained the antibacterial agent, (-)-(1R,5S,6S)-6-[(1R)-1-hydroxyethyl]-1-methyl-2-(2-N,N-dimethylamino-2-iminoethylthio)-1-carbapen-2-em-3-carboxylic acid by the method described in the above-mentioned literature. The whole reaction pathway in accordance with this invention is as follows. In the reaction pathway illustrated above, R¹, R² and R³ preferably represent hydrogen; straight-chain, branched or cyclic C₁₋₁₀ alkyl groups, for example, methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, heptyl, cyclohexyl, etc.; aralkyl groups, for example, benzyl, phenethyl, etc.; and aryl groups, for example, phenyl, β-naphthyl, etc. These hydrocarbon groups may have suitable substituents, for example, carboxyl; alkoxycarbonyl, exemplified by methoxycarbonyl, ethoxycarbonyl, etc.; amino; alkyl-substituted amino, exemplified by methylamino, ethylamino, diethylamino, etc.; hydroxyl; alkoxy, exemplified by methoxy, ethoxy, etc.; alkylsilyl, exemplified by trimethylsilyl, triethylsilyl, etc.; acyloxy, exemplified by acetyloxy, propionyloxy, etc.; halogens, exemplified by chlorine, bromine, iodine, etc.; carbamoyl; mercapto; nitrile; nitro, etc., unless they cause adverse effects on the reaction. R⁴ is a residual group derived from an alcohol which is to be used in the alcoholysis of the compound (9), and such a group includes alkyl optionally substituted by halogen(s), such as methyl, ethyl and trichloro-ethyl; and aralkyl, such as benzyl, with their numbers of carbon atoms being preferably in the range of 1 to 10. The invention described herein covers optically active β-amino acid derivatives of the following formula: wherein COOR¹ is an esterified or unesterified carboxyl group; R⁵ is hydrogen or a C₁₋₁₀ acyl or esterified carboxyl group and their salts. This invention comprehends the compounds (8) and (9) in the reaction pathway as illustrated above. As salts of the compounds of the present invention, when R¹ is 11, sodium and potassium salts may be obtained, and when R⁵ is H, hydrochlorides and sulfates may be obtained, for instance. The invention also constitutes a process for producing optically active β-amino acid derivatives of the formula: wherein COOR¹ and R⁵ are as defined hereinbefore and their salts, characterized in that said process comprises treating a compound of the following formula: wherein COOR¹ and R² are as defined hereinbefore; SR³ is a protected or unprotected mercapto group, with an acid to give a compound of the following formula: wherein COOR¹ and R² are as defined hereinbefore, and allowing a base to act on the same to give a compound of the following formula: wherein COOR¹, R² and SR³ are as defined hereinbefore, through inversion of a substituent configuration in the 5 position followed by reaction with an inorganic salt or halogenating agent. The conversion of (3) to (5) usually is carried out by treating the former with one hundredth to twice as much, of an acid, such as sulfuric acid, hydrochloric acid, perchloric acid, trifluoroacetic acid and p-toluenesulfonic acid, in such a solvent as dichloromethane, dichloroethane, chloroform, benzene, ethyl acetate, ether and THF at a temperature ranging from 0°C to 50°C. When a mixture of (3) and (4) is subjected to a reaction under the same conditions, there results a mixture of (5) and (6). Separatory purification of the resulting mixture for (5) is easily performed by column chromatography. The conversion of (5) to (7) usually is carried out by treating the former in a solvent, such as lower alcohols being exemplified by methanol, ethanol and t-butanol, aqueous acetone, acetonitrile and THF, in the presence of such a base as sodium carbonate, potassium carbonate, sodium hydroxide, potassium hydroxide, sodium methylate, sodium ethylate and potassium t-butoxide at a temperature ranging from 25°C to 100°C for 10 minutes to 24 hours. Similar treatment of a mixture of (5) and (6) also yields a mixture of (7) and unreacted (6). Separatory purification of the resulting mixture is easily performed by column chromatography and the like. The conversion of (7) to (8) usually is conducted by means of the methods (for example, the method described in Greene; "Protective Groups in Organic Synthesis", pp. 129-139) conventionally employed for the conversion of dithioacetal to carbonyl compounds. Typically, the conversion is carried out by treatment with a combination of inorganic salts, such as CuCl₂ and CuO, AgNO₃ and Ag₂O and HgCl₂ and HgO, or a halogenating agent, such as bromine, N-bromosuccinimide, N-chlorosuccinimide and 1,3-dibromo-5,5-dimethylhydantoin, in such a solvent as acetone, acetonitrile, THF and alcohols being exemplified by methanol, after being admixed with a small amount to 70 % of water, at a temperature ranging from 0°C to 100°C for 5 minutes to 24 hours. The conversion of (8) to (9) is carried out by treating the former with an acid such as hydrochloric acid and sulfuric acid in an aqueous solution at a temperature ranging from 20°C to 100°C for 1 to 48 hours. (1) and (2) are converted to (3) and (4), for example, by the following procedure; namely, (R)-3-hydroxybutyrate (1) (wherein ester moiety R¹ is as defined hereinbefore) is treated with twice to 2.5 times as much of a lithium introducing agent, such as lithium diisopropylamide, lithium bis(trimethylsilyl)amide, lithium N-t-butylcyclohexylamide and lithium 2,2,6,6-tetramethylpiperidide, in a dried solvent, such as ether, THF, 1,2-dimethoxyethane and dioxane at a temperature ranging from -78°C to 0°C for 10 minutes to 5 hours, followed by treatment at a temperature ranging from -78°C to 0°C for 10 minutes to 5 hours with a solution in the same solvent as used in the reaction, e.g. THF, of one equivalent of the compound (2) (wherein R² and R³ are as defined hereinbefore) as prepared by the method to be described below. The product is a mixture consisting of two kinds of the isomers, (3) and (4), and these two compound can be separated by column chromatography. Since the desirable isomer alone can be readily separated and purified in the subsequent step for the production of (7) or (8), however, (3) and (4) can be employed in the form of a mixture without being separated in the following step. Production of the compound (2): The compound (2) can be produced from (12) via (13) and (14) in three steps. In the first step, the conversion of (12) to (13) is carried out by treating the compound (12) (wherein R³ is as defined hereinbefore) with once to 1.2 times as much of a lithium introducing agent, such as n-butyllithium and lithium diisopropylamide, in a dried solvent, such as ether and THF, at a temperature ranging from -78°C to 30°C for 1 to 48 hours, followed by treatment with once to 1.5 times as much of pyruvic aldehyde acetal of CH₃COCH(OR⁶)₂ [wherein R⁶ is an alkyl group of 1 to 10 carbon atoms] at a temperature ranging from -78°C to 30°C for 1 to 48 hours. The conversion of (13) to (14) usually is conducted by treatment in a solvent, such as alcohols with a water content of 1 to 80 % being exemplified by methanol and ethanol, acetone, THF and dioxane, in the presence of such an acid as hydrochloric acid, sulfuric acid, phosphoric acid, perchloric acid, acetic acid, trifluoroacetic acid and p-toluenesulfonic acid at a temperature ranging from 0°C to 60°C for 10 minutes to 48 hours. Alternatively, the conversion can be performed by dissolving the compound (13) in a solvent, such as dichloromethane, chloroform, benzene, ethyl acetate and ether, followed by stirring with a 1 to 60 % aqueous solution of the above-described acid at 0°C to room temperature for 10 minutes to 48 hours. The conversion of (14) to (2) usually is carried out by treating hexamethyldisilazane and n-butyllithium in such a solvent as ether, THF, hexane and pentane at a temperature ranging from -78°C to 25°C for 10 minutes to 24 hours in accordance with the conventional method, then treating the thus-prepared solution of lithium bis(trimethylsilyl)amide with one equivalent of (14) at a temperature ranging from -78°C to 30°C for 10 minutes to 24 hours and then stirring with once to twice as much of chlorotrimethylsilane admixed at a temperature ranging from -78°C to 40°C for 30 minutes to 48 hours, followed by treatment with once to twice as much of R²COCl [wherein R² is as defined hereinbefore] at a temperature from -78°C to 30°C for 10 minutes to 48 hours. Also, the desired (2) can be obtained by utilizing twice to three times as much of R²OCOCl without adding the above mentioned chlorotrimethylsilane. The conversion of (9) to (10) usually is carried out by treating the former with an alcohol such as methanol, ethanol, benzyl alcohol, phenol and 2,2,2-trichloroethanol at a temperature ranging from 20°C to 100°C for 1 to 24 hours. Esterified portion R⁴ in the compound (10) may be the same one as in the alcohol R⁴OH used in the conversion of (9) to (10). The conversion of (10) to (11) usually is carried out by treating the former with dicyclohexylcarbodiimido (DCC) in the presence of a base such as triethylamine, pyridine, dimethylaniline and 4-dimethylaminopyridine, or an oxide such as ethylene oxide and propylene oxide in a solvent such as alcohol being exemplified by methanol and ethanol, or acetonitrile at a temperature ranging from 20°C to 100°C. The following examples are further illustrative of the present invention. Example 1 Production of 2-(1,3-dithian-2-yliden) propanal dimethylacetal [13; R³ = -(CH₂)₃-, R⁶ = CH₃] A solution of 35.2 g of 2-trimethylsilyl-1,3-dithian in 400 ml of anhydrous THF was cooled to -78°C, and n-butyllithium (0.195 mol)-hexane solution was added dropwise to the solution under stream of argon; care was taken to maintain it at a temperature of below -60°C. After completion of the addition, the reaction solution was raised gradually to 0°C over a period of 4 hours and then cooled again to -78°C, and 23.54 ml of pyruvic aldehyde dimethylacetal was gradually added dropwise to it below -60°C. After stirring was continued at the same temperature for 1 hour, the reaction solution was left on standing overnight at room temperature and poured into a mixture of 300 ml of methylene chloride and 300 ml of water, followed by thorough shaking. The methylene chloride layer was separated, dried (over MgSO₄) and concentrated under reduced pressure. The residue was distilled under reduced pressure to give 35.7 g of the objective compound. bp. 105 - 110°C/0.1 mmHg ¹H-NMR (CDCl₃) δ , 1.68(3H,s), 2.08(2H,m), 2.79(4H,m), 8.20(6H,s), 5.21(1H,s) Example 2 Production of 2-(1,3-dithian-2-yliden)propanal [14; R³ = -(CH₂)₃-] In 80 ml of chloroform was dissolved 19.0 g of 2-(1,3-dithian-2-yliden)propanal dimethylacetal [13; R³ = -(CH₂)₃-, R⁶ = CH₃], and 40 ml of a 1:1 mixture of trifluoroacetic acid and water was added to the solution under ice cooling, followed by stirring at the same temperature for 2 hours. The chloroform layer was separated, washed with water, aqueous sodium hydrogen carbonate solution and water successively and concentrated under reduced pressure. The residue was crystallized from isopropyl etherhexane to give 13.1 g of the objective compound. mp., 80 - 82°C Elemental analysis, for C₇H₁₀OS₂ Calcd.: C, 48.24; H, 5.78; S, 36.79 Found : C, 48.13; H, 5.49; S, 36.55 ¹H-NMR (CDCl₃) δ , 1.23(3H,s), 2.16(2H,m), 2.92(4H,m), 9.96(1H,s) Example 3 Production of N-methoxycarbonyl-2-(1-3-dithian-2-yliden)propanimine [2; R² = CH₃, R³ = -(CH₂)₃-] A solution of 9.8 ml of 1,1,1,3,3,3-hexamethyldisilazane in 50 ml of anhydrous THF was cooled to -78°C, and 30 ml of 1.5M n-butyllithium-hexane solution was added dropwise to the solution. After stirring was continued at the same temperature for 1 hour, a solution of 7.37 g of 2-(1,3-dithian-2-yliden)propanal [14; R³ = -(CH₂)₃-] in 30 ml of anhydrous THF was gradually added dropwise to the solution below -60°C, and stirring was continued at -78°C for another hour. After addition of 6.44 ml of chlorotrimethylsilane, the reaction solution was gradually warmed up to room temperature and then ice-cooled. To it was added 3.92 ml of methyl chloroformate gradually and dropwise. The reaction solution was left overnight in a refrigerator and concentrated to dryness under reduced pressure. The residue was extracted with methylene chloride. The extract was concentrated under reduced pressure to give 8.92 g of the objective compound in the form of crystals. mp., 89 - 91°C Elemental analysis, for C₉H₁₃NO₂S₂ Calcd.: C, 46.73; H, 5.66; N, 6.05; S, 27.72 Found : C, 46.60; H, 5.42; N, 5.97; S, 28.00 IR (CH₂Cl₂), 1700, 1565 cm⁻¹ ¹H-NMR (CDCl₃) δ , 2.07(3H,s), 2.10(2H,m), 3.07(4H,m), 3.87(3H,s), 9.34(1H,s) Example 4 Production of methyl 4-(1,3-dithian-2-yliden)-2-(R)-(1-(R)-hydroxyethyl)-3-(R,S)-methoxycarbonylaminopentanoate [3; R¹ = R² = CH₃, R³ = -(CH₂)₃-] and [4; R¹ = R² = CH₃, R³ = -(CH₂)₃-] A solution of anhydrous THF (100 ml) containing 0.042 mol of lithium diisopropylamide (prepared from n-butyllithium and diisopropylamine in accordance with the conventional method) was cooled to -70°C, and 2.36 g of methyl (R)-3-hydroxybutyrate was added dropwise to it under a stream of argon. After stirring was continued at the same temperature, for 1 hour, a solution of 4.62 g of N-methoxycarbonyl-2-(1,3-dithian-2-yliden)propanimine [2; R² = CH₃, R³ = -(CH₂)₃-] in 100 ml of anhydrous THF was gradually added dropwise to the mixed solution, and stirring was continued -78°C for 1 hour. After addition of 2.4 ml of acetic acid, the reaction solution was poured into 100 ml of water, and was extracted with ethyl acetate. The extract was washed with water dried (over MgSo₄) and concentrated under reduced pressure. The residue was purified by silica-gel column chromatography, and the eluate with benzene-ethyl acetate (7:1) yielded 1.89 g of the object compound [4; R¹ = R² = CH₃, R³ = -(CH₂)₃-]; ¹H-NMR (CDCl₃) δ , 1.22(3H,d,J=7.0Hz), 1.62(3H,s), 2.02 (2H,m), 2.47(1H,m), 2.82(4H,m), 3.56(3H,s), 3.61(3H,s), 3.82(1H,m), 5.27(1H,dd,J=9.0,6.0Hz), 5.96(1H,d,J=9.0Hz) and 4.74 g of the object compound [3; R¹ = R² = CH₃, R³ = -(CH₂)₃-]; ¹H-NMR (CDCl₃) δ , 1.15(3H,d,J=6.7Hz), 1.76(3H,s), 2.02 (2H,m), 2.76(3H,m), 3.57(3H,s), 3.58(3H,s), 3.85(1H,m), 5.45(1H,t,J=9.0Hz), 5.96(1H,d,J=9Hz), both in the form of an oily substance. Example 5 Production of (3R, 4S, 5R, 6R)-3,6-dimethyl-5- methoxycarbonyl-4-methoxycarbonylaminotetrahydropyran-2-spiro-2'-(1',3'-dithian) [5; R¹ = R² = CH₃, R³ = -(CH₂)₃-] In 100 ml of methylene chloride was dissolved 3.49 g of methyl 4-(1,3-dithian-2-yliden)-2-(R)-(1-(R)-hydroxyethyl)-3-(S)-methoxycarbonylaminopentanoate [3; R¹ = R² = CH₃, R³ = -(CH₂)₃-], and 10 ml of 0.1M HCl-methylene chloride solution was added to the solution, followed by stirring under ice-cooling for 2 hours. The reaction solution was washed with aqueous sodium hydrogen carbonate solution and concentrated under reduced pressure, and the residue was crystallized from isopropyl ether to give 3.20 g of the objective compound. mp., 72 - 74°C [α] 29 / D +166° (c = 1.0, MeOH) IR (CH₂Cl₂) 3450, 1730, 1512 cm⁻¹ ¹H-NMR (CDCl₃) δ 11.19(3H,d,J=6.9Hz), 1.34(3H,d,J=6.6Hz), 1.87-2.10(2H,m), 2.63(2H,m), 2.65(1H,dq,J=11.5,6.9Hz), 2.90(1H,m), 2.94(1H,dd,J=4.8,3.8Hz), 3.49(1H,m), 3.66 (3H,s), 3.73(3H,s), 4.00(1H,m), 4.44(1H,m), 4.88(1H,d,J=9.8Hz) Example 6 Production of (3R, 4S, 5S, 6R)-3,6-dimethyl-5-methoxycarbonyl-4-methoxycarbonylaminotetrahydropyran-2-spiro-2'-(1',3'-dithian) [7; R¹ = R² = CH₃, R³ = -(CH₂)₃-] In 100 ml of anhydrous methanol was dissolved 1.75 g of (3R, 4S, 5R, 6R)-3,6-dimethyl-5-methoxycarbonyl-4-methoxycarbonylaminotetrahydropyran-2-spiro-2' -(1',3'-dithian) [5; R¹ = R² = CH₃, R³ = -(CH₂)₃-], and 10.5 ml of 1M sodium methylate-methanol solution was added to the solution, and the mixture was heated under reflux for 8 hours. The solution was allowed to cool and admixed with 2.4 ml of acetic acid, and the solvent was distilled off under reduced pressure. The residue was dissolved in a mixture of 50 ml of methylene chloride and 20 ml of water, and the methylene chloride layer was washed with water, dried (over MgSO₄) and concentrated under reduced pressure. The residue was crystallized from isopropyl ether to give 1.36 g of the objective compound. mp., 155 - 156°C [α] 29 / D +114° (c=1.0, MeOH) Elemental analysis, for C₁₄H₂₃NO₅S₂ Calcd.: C, 48.12; H, 6.63; N, 4.01; S, 18.35 Found : C, 48.04; H, 6.62; N, 4.01; S, 18.14 IR (CH₂Cl₂) 3440, 1740, 1515 cm⁻¹ ¹H-NMR (CDCl₃) δ 1,21(3H,d,J=6.8Hz), 1.29(3H,d,J=6.15Hz), 1.80-2.12(3H,m), 2.41(1H,dd,J=10.3,10.8Hz), 2.65(2H,m), 2.94(1H,m), 3.48(1H,m), 3.70(6H,s), 4.05(1H,ddd,J=10.4, 10.5,10.8Hz), 4.32(1H,dq,J=10.3,6.15Hz), 4.65(1H,d,J=10.4Hz) Example 7 Production of methyl (2R, 3R, 4S, 5R)-2,5-dimethyl- 3-methoxycarbonylamino-5-pentanolide-4-carboxylate [8; R¹ = R² = CH₃] In 50 ml of acetone was dissolved 1.70 g of (3R, 4S, 5S, 6R)-3,6-dimethyl-5-methoxycarbonyl-4-methoxycarbonylaminotetrahydropyran-2-spiro-2'-(1',3'-dithian) [7; R¹ = R² = CH₃, R³ = -(CH₂) 3-], and 1.66 g of cupric chloride dihydrate and 1.55 g of cupric oxide were added to the solution, and the mixture was heated under reflux with stirring for 2 hours. The reaction solution was cooled with ice, and the insoluble matter was removed by filtration, whereupon the filtrate was concentrated under reduced pressure. The residue was purified by silica-gel column chromatography, and the eluate with chloroform-methanol (15:1) yielded 1.01 g of the objective compound in the form of crystals. mp., 135 - 137°C [α] 29 / D +31.4° (c = 1.1, CHCl₃) Elemental analysis, for C₁₁H₁₇NO₆ Calcd.: C, 50.96; H, 6.61; N, 5.40 Found : C, 50.70; H, 6.31; N, 5.32 IR (CH₂Cl₂) 3440, 1740, 1515 cm⁻¹ ¹H-NMR (CDCl₃) δ 1,38(3H,d,J=6.2Hz), 1.39(3H,d,J=7.1Hz), 2.67(1H,m), 2.84(1H,dd,J=10.5, 109Hz), 3.75(6H,s), 3.93 (1H,ddd,J=10.9, 10.7, 9.1Hz), 4.54(1H,dq,J=10.5, 6.2Hz) Example 8 Production of N-benzyloxycarbonyl 2-(1,3-dithian-2-yliden)propanimine [2: R² = CH₂C₆H₅, R³ = -(CH₂) 3-] By following the same procedure as described in Example 3, the reaction was carried out with use of benzyl chloroformate in place of methyl chloroformate to give the objective compound in excellent yield. mp., 85 - 88°C IR (CH₂Cl₂) 1705, 1565 cm⁻¹ ¹H-NMR (CDCl₃)δ 2.07 (3H,s), 2.20(2H,m), 3.05(4H,m), 5.28 (2H,s), 7.43(5H,s), 9.34 (1H,s) Example 9 Production of methyl 3-(R,S)-benzyloxycarbonylamino-4-(1,3-dithian-2-yliden)-2-(R)-(1-(R)-hydroxyethyl)pentanoate [3; R¹ = CH₃, R² = CH₂C₆H₅, R³ = -(CH₃)-] and [4; R¹ = CH₃, R² - CH₂C₆H₅, R³ = -(CH₂)₃-] By following the same procedure as described in Example 4, the reaction was conducted with use of N-benzyloxycarbonyl 2-(1,3-dithian-2-yliden)propanimine [2; R² = CH₂C₆H₅, R³ = -(CH₂)₃-] in place of N-methoxycarbonyl 2-(1,3-dithian-2-yliden)propanimine [2; R² = CH₃, R³ = -(CH₂)₃-] to give the objective compound in the form of an oily substance. IR (CH₂Cl₂) 3440, 1725, 1500 cm⁻¹ Example 10 Production of (3R, 4S, 5R, 6R)- and (3R, 4R, 5R, 6R)-4-benzyloxycarbonylamino-3,6-dimethyl-5-methoxycarbonyltetrahydropyran-2-spiro-2'-(1',3'-dithian) [5; R¹ = CH₃, R² = CH₂C₆H₅, R³ = -(CH₂)₃-] and (6; R¹ = CH₃, R² = CH₂C₆H₅, R³ = -(CH₂)₃-] In 200 ml of methylene chloride was dissolved 6.5 g of methyl 3-(R,S)-benzyloxycarbonylamino-4-(1,3-dithian-2-yliden)-2-(R)-(1-(R)-hydroxyethyl)-pentanoate as obtained in Example 9, and 0.1 ml of 5.2M hydrogen chloride-dioxane solution was added to the solution, followed by stirring at room temperature for 2 hours. The reaction solution was washed with aqueous sodium hydrogen carbonate solution and concentrated under reduced pressure, and the oily residue was purified by silica-gel column chromatography. The eluate with benzene-ethyl acetate (15:1) yielded 1.63 g of the objective compound [6; R¹ = CH₃, R² = CH₂C₆H₅, R³ = -(CH₂)₃]; ¹H-NMR (CDCl₃) δ 1.17(3H,d,J=6.9Hz), 1.33(3H,d,J=6.6Hz,) 1.86-2.08(2H,m) , 2.56-2.69(3H,m), 2.88(1H,m), 2.95(1H,dd, J=3.4,4.8Hz), 3.47(1H,m), 3.47(1H,m) , 3.68(3H,s), 4.08 (1H,m), 4.43(1H,m), 5.08(2H,s), 7.34(5H,m), and 4.15 g of the same [5; R¹ = CH₃, R² = CH₂C₆H₅, R³ = -(CH₂)₃-]; IR (CH₂Cl₂) 3400, 1735, 1720(sh), 1510 cm⁻¹ ¹H-NMR (CDCl₃) δ 1.17(3H,d,J=7.2Hz), 1.38(3H,d,J=6.6Hz), 1.80-2.07(2H,m), 2.60(3H,m), 2.85(1H,m), 3.00(1H,m), 3.53(1H,m), 3.72(3H,s), 4.13(1H,m), 4.29(1H,m), 5.10(2H, dd,J=1.22, 18.2Hz), 7.35(5H,m) Example 11 Production of (3R, 4S, 5S, 6R)-4-benzyloxycarbonylamino-3,6-dimethyl-5-methoxycarbonyl-tetrahydropyran-2-spiro-2'-(1',3'-dithian) [7; R¹ = CH₃, R² = CH₂C₆H₅, R³ = -(CH₂)₃-] By following the same procedure as described in Example 6, (3R, 4S, 5R, 6R) -4-benzyloxycarbonylamino-3,6-dimethyl-5-methoxycarbonyl-tetrahydrohydropyran-2-spiro-2'-(1',3'-dithian) [5; R¹ = CH₃, R² = CH₂C₆H₅, R³ = -(CH₂)₃-] was reacted with sodium methylate to give the objective compound in yield of 85 %. The crystals showed the following physical properties: mp., 145 - 146°C [α] 29 / D +81.7° (c=0.85, MeOH) IR (CH₂Cl₂) 3440, 1740, 1515 cm⁻¹ ¹H-NMR (CDCl₃) δ 1.21(3H,d,J=6.8Hz), 1.28(3H,d,J=6.2Hz), 1.75-2.11(3H,m), 2.39(1H,dd,J=10.6, 10.8Hz), 2.65(2H,m), 2.92(1H,m), 3.47(1H,m), 3.60(3H,s), 4.08(1H,ddd,J=9.6, J=9.6, 10.8, 11.1Hz), 4.32(1H,m), 4.63(1H,d,J=9.6Hz), 5.07(2H,dd,J=16.0, 12.3Hz), 7.35(5H,m) Example 12 Production of methyl (2R, 3R, 4S, 5R)-3-benzyloxycarbonylamino-2,5-dimethyl-5-pentanolide-4-carboxylate [8; R 1 = CH₃, R² = CH₂C₆H₅] By following the same procedure as described in Example 7, the objective compound was prepared in yield of 86 % from (3R, 4S, 5S, 6R)-4-benzyloxycarbonylamino-3,6-dimethyl-5-methoxycarbonyl-tetrahydropyran-2-spiro-2'-(1',3'-dithian) [7; R¹ = CH₃, R² = CH₂C₆H₅, R³ = -(CH₂)₃-]. mp., 143 - 145°C [α] 29 / D +22.4° (c=1.35, CHCl₃) Elemental analysis, for C₁₇H₂₁NO₆ Calcd.: C, 60.08; H, 6.31; N, 4.18 Found : C, 60.67; H, 6.05; N, 4.31 IR (CH₂C1₂) 3440, 1740, 1515 cm⁻¹ ¹H-NMR (CDCl₃) δ 1.37(3H,d,J-6.1Hz), 1.39 (3H,D,J=6.9Hz), 2.66(1H,m), 2.83(1H,t,J=10.9Hz), 3.63(3H,s), 3.92(1H,ddd, J=11.0, 10.9, 9.0Hz), 4.53(1H,m), 4.89(1H,d,J=9.0Hz), 5.10 (2H,s), 7.35(5H,m) Example 13 Production of (2R, 3R, 4S, 5R)-3-amino-2,5-dimethly-5-pentanolide-4-carboxylic acid (9) A mixture of 670 mg of methyl (2R, 3R, 4S, 5R)-3-benzyloxycarbonylamino-2,5-dimethyl-5-pentanolide-4-carboxylate [8; R¹ = CH₃, R² = CH₂C₆H₅] in 15 ml of concentrated hydrochloric acid was stirred overnight. The reaction solution was concentrated to dryness under reduced pressure, and the residue was dried in a vacuum desiccator at a temperature of 50°C to give 430 mg of hydrochloride of the objective compound in the form of crystals. The crystals showed the following physical properties. mp., 160 - 1630°C (decomp.) Elemental analysis, for C₈H₁₄NO₄Cl Calcd.: C, 42.96; H, 6.31; N, 6.26 Found : C, 42.86; H, 6.60; N, 5.98 Example 14 Production of methyl (2R, 3R, 4S, 5R)-3-amino-4-carboxy-5-hydroxy-2-methyl-hexanoate (10; R⁴ = CH₃) In anhydrous methanol was dissolved 430 mg of hydrochloride of (2R, 3R, 4S, 5R)-3-amino-2,5-dimethyl-5-pentanolide-4-carboxylic acid (9), and the solution was left on standing overnight. The solvent was distilled off under reduced pressure to give the hydrochloride of the objective compound, which exhibited the following absorption peaks in the ¹H-NMR spectrophotometry. ¹H-NMR (CDCl₃-DMSO d₆) δ 1.35(3H,d,J=6.2Hz), 1.42(3H,d, J=7.0Hz), 2.56(1H,m), 3.22(1H,m), 3.72(3H,s), 4.10(1H,m) 4.45(1H,m) Example 15 Production of methyl 2(R) -[(35, 4R)-3-(1(R)-hydroxy-ethyl)-2-oxoazetidine-4-yl]propanoate (11; R⁴= CH₃) In 30 ml of anhydrous methanol was dissolved 510 mg of the hydrochloride of methyl (2R, 3R, 4S, 5R)-3-amino-4-carboxy-5-hydroxy-2-methyl-hexanoate (10), and 1 ml of propene oxide was added to the solution,and the mixture was heated under reflux for 10 minutes. The solution was allowed to cool and admixed with 450 mg of DCC, and the mixture was heated with stirring at 50°C for 4 hours. The solvent was distilled off under reduced pressure, and the residue was extracted with ethyl acetate. The extract was freed of the insoluble matter by filtration and concentrated under reduced pressure, and the residue was purified by silica-gel column chromatography. The eluate with benzene-ethyl acetate (1:1) yielded 310 mg of the objective compound. The objective compound showed the following physical properties. mp., 102 - 104°C Elemental analysis, for C₆H₁₅NO₄ Calcd.: C, 53.72; H, 7.51; N, 6.96 Found : C, 53.44; H, 7.27; N, 6.93 [α] 24 / D -44.7° (c=0.45, CHCl₃) IR (CH₂Cl₂) 3410, 1768, 1735 cm⁻¹ ¹H-NMR (CDCl₃) δ 1.27(3H,d,J=7.1Hz), 1.31(3H,d,J=6.3Hz), 2.67(1H,m), 2.98(1H,dd,J=2.1, 7.0Hz), 3.72(3H,s), 3.77 (1H,dd,J=2.1, 7.7Hz), 4.16(1H,m), 6.09(1H,broad s) Example 16 By following the same procedure as described in Example 4, but using t-butyl, i-propyl and β-naphthyl as R¹, and methyl and benzyl as R², the above compounds (3) were obtained. The results are shown in the following Table 1. R¹ R² yield (2R,3S)/(2R,3R) molar ratio of the compounds (3) t-butyl benzyl 66% 2.0 t-butyl methyl 65% 1.8 i-propyl methyl 70% 2.0 β-naphtyl methyl 10% 14 Structures of the obtained compounds were confirmed by preparing to the compounds (9) through the pathway 2 to 5.

Claims: Claims for the following Contracting States : BE, CH, DE, FR, GB, IT, LI, NL, SE An optically active β-amino acid derivative of the following formula (I): wherein COOR¹ is an esterified or unesterified carboxyl group; R⁵ is hydrogen or a C₁₋₁₀ acyl or esterified carboxyl group, and salts thereof. A compound as claimed in Claim 1, wherein R⁵ represents hydrogen or COOR² and R¹ and R² independently represent hydrogen, substituted or unsubstituted C₁₋₁₀ alkyl, aralkyl, or aryl. A compound as claimed in Claim 2, wherein R¹ and R² independently represent hydrogen, methyl or benzyl. A compound as claimed in claim 1, selected from: Methyl (2R,3R,4S,5R)-3-benzyloxycarbonylamino-2, 5-dimethyl-5-pentanolide-4-carboxylate; (2R,3R,4S,5R)-3-amino-2,5-dimethyl-5-pentanolide-4-carboxylic acid; and Methyl (2R,3R,4S,5R)-3-methoxycarbonylamino-2, 5-dimethyl-5-pentanolide-4-carboxylate, and salts thereof. A process for producing a compound as claimed in Claim 2, which process comprises reacting a compound of the following formula (7): wherein COOR¹ and R² are as defined in Claim 2 and, SR³ is a protected or unprotected mercapto group, with an inorganic salt or halogenating agent in the presence of water. A process as claimed in Claim 5, wherein the compound of formula (7) is prepared by allowing a base to act on a compound of the following formula (5): wherein COOR¹, R² and SR³ are as defined in Claim 5. A process as claimed in Claim 6, wherein the compound of formula (5) is prepared by treating with acid a compound of the following formula (3): wherein COOR¹, R² and SR³ are as defined in Claim 6. A process for producing a (2R,3R,4S,5R)-3-amino-4 -carboxy-5-hydroxy-2-methyl-hexanoate which comprises treating a compound as claimed in Claim 2 wherein R¹ and R⁵ both represent hydrogen with an alcohol. A compound as claimed in Claim 1, wherein R¹ represents hydrogen. A compound as claimed in Claim 1 or Claim 9, wherein R⁵ represents hydrogen. A compound as claimed in Claim 1, wherein R¹ represents aryl. Claims for the following Contracting State : ES A process for producing an optically active β-amino acid derivative of the following formula (I): wherein COOR¹ is an esterified or unesterified carboxyl group; R⁵ is hydrogen or a C₁₋₁₀ acyl or esterified carboxyl group, and salts thereof, which process comprises reacting a compound of the following formula (7): wherein COOR¹ is as defined above, R² represents hydrogen, substituted or unsubstituted C₁₋₁₀ alkyl, aralkyl or aryl, and, SR³ is a protected or unprotected mercapto group, with an inorganic salt or halogenating agent in the presence of water. A process as claimed in Claim 1, wherein R⁵ represents hydrogen or COOR² and R¹ and R² independently represent hydrogen, substituted or unsubstituted C₁₋₁₀ alkyl, aralkyl, or aryl. A process as claimed in Claim 2, wherein R¹ and R² independently represent hydrogen, methyl or benzyl. A process as claimed in Claim 1, wherein the compound of formula (I) is selected from: Methyl (2R,3R,4S,5R)-3-benzyloxycarbonylamino-2,5-dimethyl-5-pentanolide-4-carboxylate; (2R,3R,4S,5R)-3-amino-2,5-dimethyl-5-pentanolide-4-carboxylic acid; and Methyl (2R,3R,4S,5R)-3-methoxycarbonylamino-2,5-dimethyl-5-pentanolide-4-carboxylate, and salts thereof. A process as claimed in any one of the preceding claims, wherein-the compound of formula (7) is prepared by allowing a base to act on a compound of the following formula (5): wherein COOR¹, R² and SR³ are as defined in Claim 1. A process as claimed in Claim 5, wherein the compound of formula (5) is prepared by treating with an acid a compound of the following formula (3): wherein COOR¹, R² and SR³ are as defined in Claim 5. A process for producing a (2R,3R,4S,5R)-3-amino-4-carboxy-5-hydroxy-2-methyl-hexanoate which comprises treating a compound prepared by the process of Claim 2, wherein R¹ and R⁵ both represent hydrogen with an alcohol. A process as claimed in Claim 1, wherein R¹ represents hydrogen. A process as claimed in Claim 1 or Claim 8, wherein R⁵ represents hydrogen. A process as claimed in Claim 1, wherein R¹ represents aryl.

Inventors: HATANAKA, MINORU
Applicants: HATANAKA,MINORU, KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA
Application year: 1987
Main classification: C07D309
IPC codes: C07D309